Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Pregenerate Inc. logo — Revolutionizing osteoarthritis treatment

Pregenerate Inc.

Revolutionizing osteoarthritis treatment

Founded 2019 Austria Austria 6 employees Convertible Note Total: $130.00K Biotechnology, Life Sciences +1

General Information

Company Name Pregenerate Inc.
Founded Year 2019
Location Austria Austria +1
Employees 6
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Convertible Note
Social

Get notified when Pregenerate Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Pregenerate Inc.

Pregenerate is a biotechnology startup focused on revolutionizing osteoarthritis treatment. Founded in 2019 and based in Austria, the company aims to replace expensive and inefficient animal testing in medical and pharmaceutical research. Pregenerate's products and services utilize scaleable organ-on-a-chip models to advance pharmaceutical research for arthritis treatments. By employing human cells in their model, the company helps pharmaceutical companies save billions of dollars and improve the success rates of their drugs to market. In June 2022, Pregenerate secured a Convertible Note investment from SOSV, signaling investor confidence in the company's innovative approach to addressing the global degenerative joint disease, osteoarthritis. This technology not only has the potential to impact the aging human population but also sport horses and companion animals, and in the long run, it could enable personalized treatment for arthritis patients, emphasizing the company's potential for growth and impact in the Life Sciences and Medical Devices industries.

Taxonomy: medical research, pharmaceutical, organ-on-a-chip model, arthritis treatments, animal testing alternative, degenerative joint disease, osteoarthritis, drug development, patient stratification, biomedical technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note •••••• 1
Investor
07 Jun 2022
Seed Round •••••• 1
Investor
31 May 2021
Seed Round •••••• 2
Investor
•••• •••• 		06 Oct 2020
Pre Seed Round •••••• 1
Investor
08 Jan 2019

Pregenerate Inc. Alternatives & Competitors

Pregenerate Inc. vs
Hesperos Inc.
Hesperos Inc. United States

The Human-on-a-Chip Company

Grant
64 employees
Biotechnology
Pregenerate Inc. vs
myotwin
myotwin Germany

For a better and animal-free drug development

9 employees
Pregenerate Inc. vs
Noldus Information Technology
Noldus Information Technology The Netherlands

Trust our 35+ years of experience to make your behavioral research projects a success.

127 employees
Education, Information Technology

FAQ About Pregenerate Inc.

Revolutionizing osteoarthritis treatment
Pregenerate Inc. was founded in 2019.
Pregenerate Inc. is headquartered in Austria.
Pregenerate Inc. operates in the following industries: Biotechnology, Life Sciences, Medical Devices.
Pregenerate Inc. has approximately 6 employees.
Pregenerate Inc. has completed 4 funding rounds, raising a total of $130.00K. The latest funding stage is Convertible Note.
Top alternatives and competitors to Pregenerate Inc. include Hesperos Inc., myotwin, Noldus Information Technology, DNA Genotek, Mileutis Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pregenerate Inc. and Hesperos Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Pregenerate Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy